Humira (adalimumab)

Articles Index

Humira FDA Approved
Humira, the third anti-TNF drug, has been approved to treat rheumatoid arthritis. Humira is first human monoclonal antibody.

Awaiting Approval Of Adalimumab: Humira Highly Anticipated By RA Patients
Humira (adalimumab), first fully human monoclonal antibody is highly anticipated by rheumatoid arthritis patients.